Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Xijing Hospital, Air Force Medical University, Tang Du Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407700416